Alpha-Blockade Therapy for Benign Prostatic Hyperplasia: from a Nonselective to a More Selective Alpha1A-Adrenergic Antagonist
- 1 June 1998
- Vol. 51 (6) , 861-872
- https://doi.org/10.1016/s0090-4295(98)00140-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The economics of benign prostatic hyperplasia treatment: a literature reviewClinical Therapeutics, 1996
- Benign prostatic hyperplasia:Effects on quality of life and impact on treatment decisionsUrology, 1994
- Alpha1‐adrenoceptor subtypes in the human prostateBritish Journal of Urology, 1994
- Urologists On a Tightrope: Coping with a Changing EconomyJournal of Urology, 1994
- Similar Levels of Urological Symptoms Have Similar Impact on Scottish and American Men—Although Scots Report Less SymptomsJournal of Urology, 1993
- Benign prostatic hyperplasiaPostgraduate Medicine, 1993
- Benign Prostatic Hyperplasia: Intervene or Wait?Hospital Practice, 1992
- Quantifying the Smooth Muscle Content of the Prostate Using Double-Immunoenzymatic Staining and Color Assisted Image AnalysisJournal of Urology, 1992
- The prostate: An increasing medical problemThe Prostate, 1990
- Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic HyperplasiaJournal of Urology, 1979